HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Case of Congenital Dyserythropoeitic Anemia Type IV Caused by E325K Mutation in Erythroid Transcription Factor KLF1.

Abstract
Congenital dyserythropoetic anemias (CDA) represent a heterogeneous group of inherited red cell disorders resulting in ineffective erythropoiesis. Several CDA variants have been identified. KLF1 is a transcription factor required for cell division in erythroid differentiation and maturation, and the switch from fetal to adult hemoglobin. Mutations in KLF1 gene can result in a wide range of phenotypes. This case illustrates the E325K mutation in KLF1 presenting with severe anemia in infancy, persistently elevated fetal hemoglobin, and progressive improvement with age. This case of CDA because of KLF1 mutation highlights the common features and expected disease course of CDA type IV.
AuthorsRebecca Ortolano, Melissa Forouhar, Anne Warwick, David Harper
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 40 Issue 6 Pg. e389-e391 (08 2018) ISSN: 1536-3678 [Electronic] United States
PMID29200155 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Kruppel-Like Transcription Factors
  • erythroid Kruppel-like factor
Topics
  • Amino Acid Substitution
  • Anemia, Dyserythropoietic, Congenital (genetics, physiopathology)
  • Female
  • Humans
  • Kruppel-Like Transcription Factors (genetics)
  • Mutation, Missense

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: